Tag Archives: Fatty Acids

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Posted on November 3, 2017 by Dementia and Elderly Care News

Summary A LipiDiDiet trial investigated the effects of Fortasyn Connect on cognitive decline (and related measures) in the early stages of Alzheimer’s Disease. This small trial indicates that Nutricia’s nutrient drink Souvenaid has no significant effect on the rate of … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Nutrition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Alzheimer Center Limburg: University of Maastricht, Alzheimer Center: VU University Medical Center, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s and Dementia (Journal), Amsterdam Neuroscience: VU University Medical Center, BBC Health News, Behind the Headlines, Care Sciences and Society: Karolinska Institute, Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Clinical Trials Unit: Karolinska University Hospital, Cognitive Impairment, Conversion to Dementia From Prodromal Disease, Department of Clinical Geriatrics: Karolinska Institute, Department of Experimental Neurology: Saarland University, Department of Geriatric Medicine: Karolinska University Hospital, Department of Neurobiology: Karolinska Institute, Department of Neurology: Kuopio University Hospital, Department of Neurology: University of Eastern Finland, Department of Neurology: VU University Medical Center, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy at University of Gothenburg, Department of Psychiatry and Neuropsychology: University of Maastricht, European Commission 7th Framework Programme, European Community’s Seventh Framework Programme, Fatty Acids, Finland, Fortasyn Connect, German Institute for Dementia Prevention (DIDP), Germany, Improving Nutritional Care, Institute of Clinical Medicine: University of Eastern Finland, Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Karolinska Institutet, Karolinska Institutet (Stockholm), Karolinska University Hospital, Kuopio University Hospital, Lancet Neurology, LipiDiDiet Trial, Medical Faculty: Saarland University, Netherlands, Neuneuropsychological Test Battery (NTB), NeuroCenter Kuopio University Hospital, NL-ENIGMA Trial, Nutricia Advanced Medical Nutrition, Nutricia’s Souvenaid Drink, Nutrients, Nutrition and Dementia, Nutrition Support, Nutritional Approaches to Slowing or Arresting Cognitive Impairment / Dementia, Nutritional Interventions, Nutritional Supplementation, Oral Nutritional Supplements, Pentara Corporation (Salt Lake City), Preclinical Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Saarland University (Homburg), Sahlgrenska Academy: University of Gothenburg, Sahlgrenska University Hospital, Souvenaid Drink (Nutricia), Sweden, University of Eastern Finland, University of Gothenburg, University of Maastricht, USA, Vitamins, VU University Medical Center | Leave a comment

Systematic Review of Treatments to Prevent Cognitive Decline (CMAJ: Journal of the Canadian Medical Association)

Posted on April 27, 2013 by Dementia and Elderly Care News

Summary This systematic review examined the best 32 randomised controlled trials (RCTs) investigating treatments for cognitive decline, including drug treatments, hormone therapies, nutritional supplements, physical activity and cognitive exercises. The authors looked comprehensively at pharmacological treatments and non-pharmacological treatments in healthy … Continue reading →

Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Systematic Reviews | Tagged Behind the Headlines, Brain Training, Canada, Canadian Medical Association Journal, Cholinesterase Inhibitors, CMAJ: Canadian Medical Association Journal, Cognitive Activity and Cognitive Decline, Cognitive Decline, Cognitive Decline Studies, Cognitive Exercises, Cognitive Impairment, Cognitive Stimulation Therapy, Cognitive Training, Cognitive Training Exercises, DHEA (Synthetic Version of Hormone Produced by Adrenal Glands), Divisions of Geriatric Medicine and General Internal Medicine: University of Toronto, Estrogens, Exercise, Exercise for Cognitive Impairment, Exercise Regimens, Fatty Acids, Fish Oil, Fish-Oil Supplements, Ginkgo Biloba Extract, Hormonal Therapies, Hormone Therapy (HT), Journal de l'Association Medicale Canadienne, MCI, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Moderate Exercise, NMDA (N-Methyl-D-Aspartate), Nutritional Supplements, Oestrogens, Omega-3 Fatty Acids, Omega-3 PUFA Supplementation (Dietary), Oral Nutritional Supplements, Oral Nutritional Supplements (ONS), Polyunsaturated Fatty Acids (PUFA), Prevention, Prophylaxis, PUFA: Polyunsaturated Fatty Acids, Sudoku, Testosterone, University of Toronto, Vitamin Pills | Leave a comment

Omega 3 Fatty Acid for Prevention of Cognitive Decline and Dementia (Cochrane Database / NHS Choices / AHRQ)

Posted on June 24, 2012 by Dementia and Elderly Care News

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 1, August 2012]. Summary Diets high in omega-3 long-chain polyunsaturated fatty acids (PUFA) had recently been suggested in some quarters to help protect people … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), In the News, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged Agency for Healthcare Research and Quality (AHRQ), Agency for Healthcare Research and Quality (US), Behind the Headlines, Cochrane Injuries Group, Cognitive Assessment Tests, Comparative Effectiveness Review Summary Guides for Clinicians (AHRQ), DHA: Docosahexaenoic Acid, Digit Span, Docosahexaenoic Acid, Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), EPA: Eicosapentaenoic Acid, Fatty Acids, Fish, Fish-Oil Supplements, Gel Capsules of Omega-3 PUFA, Incident Dementia, John M. Eisenberg Center for Clinical Decisions and Communications Science, Linseed, London School of Hygiene and Tropical Medicine, Margarine Spreads Containing Omega-3 PUFA, Mini-Mental State Examination, MMSE: Mini-Mental State Examination, Omega-3 Fatty Acids, Omega-3 Fatty Acids and Cardiovascular Disease, Omega-3 is Ineffective in Slowing Alzheimer's Disease, Omega-3 PUFA Supplementation (Dietary), Polyunsaturated Fatty Acids (PUFA), PUFA: Polyunsaturated Fatty Acids, Tan Tock Seng Hospital (Singapore), Tests of Cognitive Function, Verbal Fluency, Word Learning | Leave a comment

Tag Archives: Fatty Acids

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Systematic Review of Treatments to Prevent Cognitive Decline (CMAJ: Journal of the Canadian Medical Association)

Omega 3 Fatty Acid for Prevention of Cognitive Decline and Dementia (Cochrane Database / NHS Choices / AHRQ)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites